dry eye

How sleep affects the ocular surfaceAt every age we need adequate, uninterrupted sleep for optimal, wakeful functioning. Insufficient sleep is associated with a number of chronic diseases and conditions such as diabetes, cardiovascular disease, obesity, and depression.
Intense pulsed light bridges eye care and aestheticsWhat is this age-defying modern technology that a young, nonmedical professional is applying to her face? It is a YAG laser combined with an intense pulse light (IPL).
Presbyopic IOLs changing game for astigmatic patientsPresbyopia-correcting IOLs are changing the preoperative patient education discussion, making it easier for surgeons. However, the need for precision measurements and careful surgical technique may be more important than in the past.
New products, advancements in dry eyeDavid Kading, OD, FAAO, FCLSA, discusses new products, studies, and patient education available to help combat dry eye disease.
Understanding the link between MGD and OSDMeibomian gland dysfunction (MGD) may be misdiagnosed. While MGD is one of the most common chronic ocular conditions, diagnosing MGD isn’t as simple as it seems.
How to use tear osmolarity to help treat dry eye diseaseFor the patient, perhaps the most significant symptom of DED is fluctuating or reduced vision.
Cataract surgery for patients with PXFMom has pseudoexfoliation syndrome (PXF) clinically visible in both eyes. She experiences pops of elevated intraocular pressure (IOP) in one eye and uses glaucoma medications.
The utility of normal tear osmolarity results
The utility of normal tear osmolarity resultsPatient symptoms are not an effective method to diagnose dry eye, as they often overlap with other pathologies. Tear osmolarity results provide clues for alternative diagnoses.
Lifitegrast data support dry eye efficacy over placebo dropsLifitegrast ophthalmic solution 0.05% (Xiidra, Shire) has demonstrated positive results for the treatment of the signs and symptoms of dry eye disease. Eye dryness scores for some patients have improved after two weeks of treatment with the topical drop.
Protein agent may change approach to treating dry eye, inflammationRecombinant human lubricin showed potential as a new therapeutic approach to the management of dry eye disease in a small clinical trial. Compared with sodium hyaluronate, lubricin (Lubris BioPharma), significantly improved both signs and symptoms of moderate dry eye after two weeks of treatment.